DigiPath (OTCBB:DIGP) announced that its subsidiary has been picked by Orange Photonics to evaluate its LightLab Marijuana Potency Analyzer.
As quoted in the press release:
The LightLab Analyzer is a portable photonics based instrument that provides an instant analysis of THC-A, delta-9 THC, CBD-A and CBD potency levels present in cannabis samples.
“There is an emerging market for rapid potency analytics outside of certified cannabis testing labs,” says DigiPath Labs Chief Science Officer, Cindy Orser, “these instruments are designed to be rugged, portable and accurate for the four cannabinoids: THCA, delta-9 THC, CBDA and CBD.”
DigiPath Labs will systematically collect comparative cannabinoid data from 100 cannabis flower samples using both the LightLab Analyzer and its own state-of-the art testing laboratory. This dataset will enable Orange Photonics to validate its calibration software and provide it with needed data for the marketing of its new LightLab device.
“We are excited to be working with DigiPath Labs in Las Vegas to help validate the LightLab Marijuana Potency Analyzer. We chose to work with Digipath because of their mission-driven commitment to consistent, accurate testing options and standards for the industry,” says Dylan Wilks, CEO/CTO of Orange Photonics. “Third party validation is essential for us to ensure the LightLab provides the level of performance the industry wants.”